ArticleBlood neoplasia2026

Dual FLT3/PIM inhibitor dapolsertib in acute myeloid leukemia: results from the phase 1/2 DIAMOND-01 trial.

Giovanni Martinelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.